Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...

Swiss biotech company Nouscom raised 120 million euros ($134.9 million) in a funding round led by Revelation Partners and the venture-capital fund of Germany's Merck KGaA that added Intesa Sanpaolo's ...

After four successive days of gains, Germany's benchmark index DAX shed some ground Friday morning, weighed down by higher oil prices and weakness in the tech sector following disappointing earnings ...

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the ...

Highly rated biotech stocks Roivant SciencesROIV and PharvarisPHVS hit record highs Tuesday on "blowout" and "bull case" results for lung and swelling disease treatments. Roivant's drug, mosliciguat, ...

Merck said it is offering $20 in cash for each American depositary share for Nasdaq-listed Silence Therapeutics, more than double the target’s closing price as of Friday.